Fully Human

Diverse

The MIMIC® process can include a diverse donor pool comprising hundreds of individuals.

Comprehensive

The MIMIC® System models innate and/or adaptive and functional immune responses; analysis is available for cytokines, APCs, T cells, and B cells for a better selection of drug candidates for clinical evaluation.

Cost Effective

Because the MIMIC® System is predictive, it can lead to faster cycle times for discovery and reduce the time and costs to bring drugs to the market.

Standard immunotoxicity tests use in vitro PBMC assays and animal models (usually rodents) to determine whether a drug, vaccine, or other product induces a potentially adverse immune response. Unfortunately, these tests can sometimes produce misleading results. VaxDesign has shown that the MIMIC® System is more sensitive and accurate than standard PBMC assays.

We have also shown that the MIMIC® System reproduces human responses to immunosuppressants and immunopotentiators, in some cases where rodent and non-human primate studies did not.